BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36046479)

  • 21. High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.
    He T; Surdez D; Rantala JK; Haapa-Paananen S; Ban J; Kauer M; Tomazou E; Fey V; Alonso J; Kovar H; Delattre O; Iljin K
    Gene; 2017 Jan; 596():137-146. PubMed ID: 27760381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study.
    Zivanovic Bujak A; Weng CF; Silva MJ; Yeung M; Lo L; Ftouni S; Litchfield C; Ko YA; Kuykhoven K; Van Geelen C; Chandrashekar S; Dawson MA; Loi S; Wong SQ; Dawson SJ
    PLoS Med; 2020 Oct; 17(10):e1003363. PubMed ID: 33001984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interlaboratory assessment of droplet digital PCR for quantification of BRAF V600E mutation using a novel DNA reference material.
    Dong L; Wang X; Wang S; Du M; Niu C; Yang J; Li L; Zhang G; Fu B; Gao Y; Wang J
    Talanta; 2020 Jan; 207():120293. PubMed ID: 31594564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic EWS-FLI1 fusion sequences in Ewing sarcoma resemble breakpoint characteristics of immature lymphoid malignancies.
    Berger M; Dirksen U; Braeuninger A; Koehler G; Juergens H; Krumbholz M; Metzler M
    PLoS One; 2013; 8(2):e56408. PubMed ID: 23441188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct comparison study between droplet digital PCR and a combination of allele-specific PCR, asymmetric rapid PCR and melting curve analysis for the detection of BRAF V600E mutation in plasma from melanoma patients.
    Tzanikou E; Haselmann V; Markou A; Duda A; Utikal J; Neumaier M; Lianidou ES
    Clin Chem Lab Med; 2020 Oct; 58(11):1799-1807. PubMed ID: 31953992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma.
    Tang SW; Bilke S; Cao L; Murai J; Sousa FG; Yamade M; Rajapakse V; Varma S; Helman LJ; Khan J; Meltzer PS; Pommier Y
    Clin Cancer Res; 2015 Sep; 21(18):4184-93. PubMed ID: 25779942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preanalytical blood sample workup for cell-free DNA analysis using Droplet Digital PCR for future molecular cancer diagnostics.
    van Ginkel JH; van den Broek DA; van Kuik J; Linders D; de Weger R; Willems SM; Huibers MMH
    Cancer Med; 2017 Oct; 6(10):2297-2307. PubMed ID: 28940814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detecting Circulating Tumor DNA in Hepatocellular Carcinoma Patients Using Droplet Digital PCR Is Feasible and Reflects Intratumoral Heterogeneity.
    Huang A; Zhang X; Zhou SL; Cao Y; Huang XW; Fan J; Yang XR; Zhou J
    J Cancer; 2016; 7(13):1907-1914. PubMed ID: 27698932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiplex detection of ctDNA mutations in plasma of colorectal cancer patients by PCR/SERS assay.
    Lyu N; Rajendran VK; Diefenbach RJ; Charles K; Clarke SJ; Engel A; ; Rizos H; Molloy MP; Wang Y
    Nanotheranostics; 2020; 4(4):224-232. PubMed ID: 32923312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing Sarcoma.
    Ishii M; Ando J; Yamazaki S; Toyota T; Ohara K; Furukawa Y; Suehara Y; Nakanishi M; Nakashima K; Ohshima K; Nakauchi H; Ando M
    Cancer Immunol Res; 2021 Oct; 9(10):1175-1186. PubMed ID: 34385178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Precision diagnostics of Ewing's sarcoma by liquid biopsy: circulating
    Allegretti M; Casini B; Mandoj C; Benini S; Alberti L; Novello M; Melucci E; Conti L; Covello R; Pescarmona E; Milano GM; Annovazzi A; Anelli V; Ferraresi V; Biagini R; Giacomini P
    Ther Adv Med Oncol; 2018; 10():1758835918774337. PubMed ID: 29899761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined multimodal ctDNA analysis and radiological imaging for tumor surveillance in Non-small cell lung cancer.
    Metzenmacher M; Hegedüs B; Forster J; Schramm A; Horn PA; Klein CA; Bielefeld N; Ploenes T; Aigner C; Theegarten D; Schildhaus HU; Siveke JT; Schuler M; Lueong SS
    Transl Oncol; 2022 Jan; 15(1):101279. PubMed ID: 34800919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous Ultra-Sensitive Detection of Structural and Single Nucleotide Variants Using Multiplex Droplet Digital PCR in Liquid Biopsies from Children with Medulloblastoma.
    Arthur C; Jylhä C; de Ståhl TD; Shamikh A; Sandgren J; Rosenquist R; Nordenskjöld M; Harila A; Barbany G; Sandvik U; Tham E
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of circulating tumor DNA (ctDNA) by digital droplet polymerase chain reaction (dd-PCR) in liquid biopsies.
    Valpione S; Campana L
    Methods Enzymol; 2019; 629():1-15. PubMed ID: 31727235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ewing family tumors: potential prognostic value of reverse-transcriptase polymerase chain reaction detection of minimal residual disease in peripheral blood samples.
    de Alava E; Lozano MD; Patiño A; Sierrasesúmaga L; Pardo-Mindán FJ
    Diagn Mol Pathol; 1998 Jun; 7(3):152-7. PubMed ID: 9836070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Droplet digital PCR-based detection of circulating tumor DNA from pediatric high grade and diffuse midline glioma patients.
    Izquierdo E; Proszek P; Pericoli G; Temelso S; Clarke M; Carvalho DM; Mackay A; Marshall LV; Carceller F; Hargrave D; Lannering B; Pavelka Z; Bailey S; Entz-Werle N; Grill J; Vassal G; Rodriguez D; Morgan PS; Jaspan T; Mastronuzzi A; Vinci M; Hubank M; Jones C
    Neurooncol Adv; 2021; 3(1):vdab013. PubMed ID: 34169282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PEAC: An Ultrasensitive and Cost-Effective MRD Detection System in Non-small Cell Lung Cancer Using Plasma Specimen.
    Xu J; Pu Y; Lin R; Xiao S; Fu Y; Wang T
    Front Med (Lausanne); 2022; 9():822200. PubMed ID: 35308511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liquid Biopsies for Monitoring Medulloblastoma: Circulating Tumor DNA as a Biomarker for Disease Progression and Treatment Response.
    Buccilli B; Rodriguez Molina MA; Redrovan Palomeque DP; Herrera Sabán CA; C Caliwag FM; Contreras Flores CJS; Abeysiriwardana CWJ; Diarte E; Arruarana VS; Calderon Martinez E
    Cureus; 2024 Jan; 16(1):e51712. PubMed ID: 38313884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highly Specific Droplet-Digital PCR Detection of Universally Methylated Circulating Tumor DNA in Endometrial Carcinoma.
    Beinse G; Borghese B; Métairie M; Just PA; Poulet G; Garinet S; Parfait B; Didelot A; Bourreau C; Agueeff N; Lavollé A; Terris B; Chapron C; Goldwasser F; Leroy K; Blons H; Laurent-Puig P; Taly V; Alexandre J
    Clin Chem; 2022 Jun; 68(6):782-793. PubMed ID: 35323926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotyping of circulating cell-free DNA enables noninvasive tumor detection in myxoid liposarcomas.
    Braig D; Becherer C; Bickert C; Braig M; Claus R; Eisenhardt AE; Heinz J; Scholber J; Herget GW; Bronsert P; Fricke A; Follo M; Stark GB; Bannasch H; Eisenhardt SU
    Int J Cancer; 2019 Aug; 145(4):1148-1161. PubMed ID: 30779112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.